JP2022545737A5 - - Google Patents

Info

Publication number
JP2022545737A5
JP2022545737A5 JP2022513534A JP2022513534A JP2022545737A5 JP 2022545737 A5 JP2022545737 A5 JP 2022545737A5 JP 2022513534 A JP2022513534 A JP 2022513534A JP 2022513534 A JP2022513534 A JP 2022513534A JP 2022545737 A5 JP2022545737 A5 JP 2022545737A5
Authority
JP
Japan
Prior art keywords
hsa
mir
meso
approximately
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022513534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545737A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/048076 external-priority patent/WO2021041591A1/en
Publication of JP2022545737A publication Critical patent/JP2022545737A/ja
Publication of JP2022545737A5 publication Critical patent/JP2022545737A5/ja
Priority to JP2025158999A priority Critical patent/JP2026001090A/ja
Pending legal-status Critical Current

Links

JP2022513534A 2019-08-28 2020-08-27 血管疾患を処置する組成物および方法 Pending JP2022545737A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025158999A JP2026001090A (ja) 2019-08-28 2025-09-25 血管疾患を処置する組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962892724P 2019-08-28 2019-08-28
US62/892,724 2019-08-28
PCT/US2020/048076 WO2021041591A1 (en) 2019-08-28 2020-08-27 Compositions and methods of treating vascular diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025158999A Division JP2026001090A (ja) 2019-08-28 2025-09-25 血管疾患を処置する組成物および方法

Publications (2)

Publication Number Publication Date
JP2022545737A JP2022545737A (ja) 2022-10-28
JP2022545737A5 true JP2022545737A5 (https=) 2023-09-05

Family

ID=72428364

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022513534A Pending JP2022545737A (ja) 2019-08-28 2020-08-27 血管疾患を処置する組成物および方法
JP2025158999A Pending JP2026001090A (ja) 2019-08-28 2025-09-25 血管疾患を処置する組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025158999A Pending JP2026001090A (ja) 2019-08-28 2025-09-25 血管疾患を処置する組成物および方法

Country Status (13)

Country Link
US (1) US20220288131A1 (https=)
EP (1) EP4022038A1 (https=)
JP (2) JP2022545737A (https=)
KR (1) KR20220049618A (https=)
CN (1) CN115003794A (https=)
AU (1) AU2020337444A1 (https=)
BR (1) BR112022003659A2 (https=)
CA (1) CA3151636A1 (https=)
IL (1) IL290891A (https=)
MX (1) MX2022002418A (https=)
PH (1) PH12022550392A1 (https=)
TW (1) TW202122573A (https=)
WO (1) WO2021041591A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108697641A (zh) 2015-08-18 2018-10-23 安斯泰来再生医药协会 临床制剂
EP4372079A4 (en) * 2021-07-15 2025-07-30 Astellas Pharma Inc PERICYTE-LIKE CELLS EXPRESSING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AT A HIGH LEVEL
CN114231481B (zh) * 2021-12-21 2023-07-18 中国人民解放军总医院 一种重编程真皮成纤维细胞为内皮祖细胞的化学诱导方法
US20240228975A9 (en) * 2022-07-19 2024-07-11 Lung Biotechnology Pbc Methods for Differentiating Endothelial Cells
CN118177150B (zh) * 2024-04-15 2024-12-03 中国医学科学院医学实验动物研究所 遗传多样性高血压小鼠模型的建立与基因转录调控分析

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106434527A (zh) 2006-04-14 2017-02-22 安斯泰来再生医药协会 血管瘤集落形成细胞
CA3186451A1 (en) * 2008-05-06 2009-11-12 Astellas Institute For Regenerative Medicine Hemangio colony forming cells and non-engrafting hemangio cells
WO2010001375A1 (en) * 2008-06-30 2010-01-07 University College Cork, National University Of Ireland, Cork Primitive vascular progenitor cells and uses thereof
US20110305672A1 (en) * 2008-07-25 2011-12-15 University Of Georgia Research Foundation, Inc. COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME
US20140045265A1 (en) * 2011-02-16 2014-02-13 Salk Institute For Biological Studies Robust and efficient differentiation of human pluripotent stem cells to multipotent vascular progenitors
RU2618871C2 (ru) * 2011-06-09 2017-05-11 Ф. Хоффманн-Ля Рош Аг Способ дифференциации плюрипотентных стволовых клеток в клетки сосудистого русла
WO2013069661A1 (ja) * 2011-11-08 2013-05-16 国立大学法人名古屋大学 iPS細胞由来血管前駆細胞シート及びその作製方法
SI2785359T1 (sl) 2011-11-30 2018-11-30 Astellas Institute For Regenerative Medicine Mezenhimske stromalne celice in uporabe povezane z njimi
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
WO2015153586A1 (en) * 2014-03-31 2015-10-08 The Johns Hopkins University Pluripotent stem cell therapies for ischemic retinopathies
GB201408712D0 (en) * 2014-05-16 2014-07-02 Univ Leuven Kath Mesodermal progenitor cells
SG11201706706XA (en) * 2015-02-20 2017-09-28 Wisconsin Alumni Res Found Generating arterial endothelial cell populations
WO2016185457A1 (en) * 2015-05-19 2016-11-24 Yeda Research And Development Co. Ltd. Methods of promoting lymphangiogenesis
JP6531335B2 (ja) * 2015-07-17 2019-06-19 国立大学法人京都大学 血管内皮細胞の誘導方法
JP6646311B2 (ja) * 2015-07-17 2020-02-14 国立大学法人京都大学 多能性幹細胞から中胚葉前駆細胞および血液血管前駆細胞への分化誘導法
CN108697641A (zh) 2015-08-18 2018-10-23 安斯泰来再生医药协会 临床制剂
WO2018031404A1 (en) * 2016-08-10 2018-02-15 Indiana University Research And Technology Corporation Method for generating mesoderm and/or endothelial colony forming cell-like cells having in vivo blood vessel forming capacity
WO2019152483A1 (en) * 2018-01-30 2019-08-08 University Of Georgia Research Foundation, Inc. Methods for vascular construction and products therefrom

Similar Documents

Publication Publication Date Title
JP2022545737A5 (https=)
Klimczak et al. Muscle stem/progenitor cells and mesenchymal stem cells of bone marrow origin for skeletal muscle regeneration in muscular dystrophies
US11452797B2 (en) Use of perfusion decellularized liver for islet cell recellularization
KR101766801B1 (ko) 중배엽 유래 ｉｓｌ+1 다분화능 전구 세포, 심장외막 전구 세포 및 다분화능 ｃｘｃｒ4+ｃｄ56+ 세포의 조성물 및 사용 방법
RU2535966C2 (ru) Клеточная терапия ишемической ткани
CN104428410B (zh) 胰激素产生细胞的制造方法及胰激素产生细胞、以及分化诱导促进剂
JP2012070731A (ja) ヒト多能性幹細胞からの造血幹細胞の効率的な誘導方法
CN106459904B (zh) 用于生成内皮集落形成细胞状细胞的方法
CA2796888A1 (en) Physiological methods for isolation of high purity cell populations
JP2026001090A (ja) 血管疾患を処置する組成物および方法
EP2872620B1 (en) Derivation and self-renewal of isi1+ cells and uses thereof
JP2023536421A (ja) 多能性幹細胞由来細胞の大規模製造のための閉鎖型製造プロセス
Hojjat et al. The differentiation and generation of glucose-sensitive beta like-cells from menstrual blood-derived stem cells using an optimized differentiation medium with platelet-rich plasma (PRP)
JP7479466B2 (ja) 血管内皮細胞純粋分離方法、血管内皮細胞特性維持培地及びそれを含む培養方法
KR102258053B1 (ko) 혈관 내피세포 순수 분리 방법
KR102281535B1 (ko) 줄기세포 유래 간오가노이드의 제작 및 제１형 혈우병 세포치료제로서의 용도
JP5794510B2 (ja) 造血幹細胞の効率的な誘導および増幅方法
EP2970902B1 (en) Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix
CN113897331B (zh) 一种诱导人源动脉内皮细胞的分化方法
JP2024531682A5 (https=)
RU2022107919A (ru) Композиции и способы лечения сосудистых заболеваний
JPWO2018128177A1 (ja) インスリン産生細胞分化誘導促進剤
CN116179469A (zh) 一种胰岛星状细胞向胰岛β样细胞分化的诱导方法
Jalil et al. Challenges in deriving and utilizing stem cell-derived endothelial cells for regenerative medicine: a key issue in clinical therapeutic applications
JP2023524572A (ja) 心内膜細胞を作製および使用するための方法および組成物